Basics Beam Therapeutics Inc. IPO Date: February 6, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.67B Activated in VL: True Average Daily Range Avg Daily Range: $1.59 | 3.49% Avg Daily Range (30 D): $0.37 | 2.14% Avg Daily Range (90 D): $0.81 | 3.75% Institutional Daily Volume Avg Daily Volume: .88M Avg Daily Volume (30 D): 1.59M Avg Daily Volume (90 D): 1.9M Trade Size Avg Trade Size (Sh.): 58 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 69 Institutional Trades Total Inst.Trades: 2,950 Avg Inst. Trade: $3.15M Avg Inst. Trade (30 D): $2.57M Avg Inst. Trade (90 D): $2.91M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.86M Avg Closing Trade (30 D): $3.76M Avg Closing Trade (90 D): $5.09M Avg Closing Volume: 131.2K     News Jun 17, 2025 @ 2:07 PM Editas Medicine Is Great. Here's Why You Shouldn't... Source: Dan Victor May 29, 2025 @ 8:01 PM Beam Therapeutics Announces U.S. FDA Orphan Drug D... Source: N/A May 6, 2025 @ 9:05 PM Why Beam Therapeutics Stock Tanked on Tuesday Source: Eric Volkman Mar 10, 2025 @ 10:01 AM Beam Therapeutics Announces Pricing of Underwritte... Source: N/A Feb 24, 2025 @ 12:00 PM Beam Therapeutics to Participate in Upcoming March... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-4.61 $-1.24 $-1.09 Diluted EPS $-4.61 $-1.24 $-1.09 Revenue $ 63.58M $ 7.47M $ 30.07M Gross Profit $ $ $ Net Income / Loss $ -387.34M $ -109.27M $ -90.35M Operating Income / Loss $ -430.72M $ -119.29M $ -100.04M Cost of Revenue $ $ $ Net Cash Flow $ 240.22M $ 244.41M $ 53.36M PE Ratio